Luca Ambrosio

ORCID: 0000-0002-6312-7709
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Nonmelanoma Skin Cancer Studies
  • Cutaneous Melanoma Detection and Management
  • Dermatology and Skin Diseases
  • Genetic and rare skin diseases.
  • Cancer and Skin Lesions
  • Hedgehog Signaling Pathway Studies
  • Drug-Induced Adverse Reactions
  • Allergic Rhinitis and Sensitization
  • Pesticide Exposure and Toxicity
  • Urticaria and Related Conditions
  • COVID-19 and healthcare impacts
  • Infectious Diseases and Tuberculosis
  • Vascular Anomalies and Treatments
  • Cutaneous lymphoproliferative disorders research
  • Food Allergy and Anaphylaxis Research
  • Pulmonary Hypertension Research and Treatments
  • Trauma and Emergency Care Studies
  • Venous Thromboembolism Diagnosis and Management
  • Contact Dermatitis and Allergies
  • Autoimmune and Inflammatory Disorders
  • melanin and skin pigmentation
  • Syphilis Diagnosis and Treatment
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Sarcoidosis and Beryllium Toxicity Research
  • Dermatological and COVID-19 studies

Sapienza University of Rome
2021-2025

Istituti di Ricovero e Cura a Carattere Scientifico
2024-2025

Istituto Dermopatico dell'Immacolata
2024

Policlinico Umberto I
2022

Syphilis is characterized by a wide range of variable clinical symptoms; therefore, it often referred to as "The Great Imitator". Here, we report the case 69-year-old hepatitis-C-positive MSM patient, who was admitted our clinic due solitary firm painless erythematous maculopapular lesion with central crater-like crust on upper right thigh that occurred two months prior. The dermoscopy showed an erythematous, copper-colored, oval diffuse monomorphic dotted and glomerular vessels, crust,...

10.3390/ijerph20021339 article EN International Journal of Environmental Research and Public Health 2023-01-11

Atopic dermatitis (AD) is a chronic inflammatory skin disease characterized by pruritus and relapsing course, affecting approximately 25% of children 4–7% adults. This study evaluated the efficacy, safety, quality-of-life impact tralokinumab, humanized monoclonal antibody targeting interleukin-13 (IL-13), in treating moderate-to-severe AD real-world setting, with focus on different phenotypes. An observational cohort 30 adults treated tralokinumab for ≥ 16 weeks was analyzed. Clinical...

10.1007/s13555-025-01341-1 article EN cc-by-nc Dermatology and Therapy 2025-01-25

Patients affected by pre-existing chronic spontaneous/Inducible urticaria (CSU/CIU) still feel unsafe due to the potential risk of an Adverse Event Following Immunization (AEFI) and Cutaneous Reactions (CARs) COVID-19 vaccines. The appropriate management in this field remains debated evidence is lacking. We considered 160 CSU/CIU patients Omalizumab/antihistamine therapy who received two doses Comirnaty/Moderna mRNA vaccines; 20 them also a booster dose. Urticaria Activity Score-7 (UAS7) was...

10.3390/jcm11071822 article EN Journal of Clinical Medicine 2022-03-25

Introduction: The incidence of melanoma increased considerably in recent decades, representing a significant public health problem. We aimed to evaluate the ability non-specialists for preliminary screening skin lesions identify melanoma-suspect lesions. Materials and Methods: A medical student dermatologist specialist examined total body scans 50 patients. Results: agreement between expert non-specialist was 87.75% (κ = 0.65) regarding assessment clinical significance. four parameters ABCD...

10.3390/diagnostics12112821 article EN cc-by Diagnostics 2022-11-16
Leandro Siragusa Roberta Angelico Marco Angrisani Biagio Zampogna Marco Materazzo and 95 more Roberto Sorge Luca Giordano Roberto Luca Meniconi Alessandro Coppola Annarita Marino Giorgio Giraudo Sofia Esposito Alessia Urbani Matteo De Pastena Rodolfo Francesco Mastrapasqua Mattia Garancini Alice Frontal G. R. Pascal Jacopo Martellucc Francesco Falb Alessandro Boscarelli Pietro Bertoglio Eleonora M. C. Trecca Luca Galassi Vincenzo Vento Ambra Chiappini Alessandro Antonelli Francesco Bennardo Filippo Familiari Giuseppe Giannaccare Andrea Zappia Giuseppe Giuliani Francesca Falcone Stefano Sebastiani Mauro Montuori Stefano Rossi Andrea Sagnotta Beatrice Giuliani Giusy Carmen Imbriani Stefano Restaino Lorenzo Andreani Fabrizio Di Maria Antonio Simone Laganà Livio Vitiello Federico Berton Edoardo Virgilio Marco Palisi Luca Portigliotti Marco Calussi Luigi Conti Claudio Mauriello Mirko Barone Edoardo Saladino Alessia Giaquinta Domenico Zerb Giuseppe Frazzetta Giovanni Merola Andréa Chierici Roberto Bini Leonardo Centonze Riccardo De Carlis Luca Ferrario Alessandro Giani Andrea Lauterio Nicolò Tamini Stefano Corti Emanuele Botteri Jacopo Andreuccetti Rossella D’Alessio Giovanni Cestaro Guglielmo Clarizia Alessandro Spolini A.S.L. Carboni Enrico Benzoni Giampaolo Galiffa Bruno Perotti Massimiliano Veroux Valentina Randazzo D. Topa Chiara Pranteda Massimiliano Veroux Giorgia Contini Chiara Iacusso Valerio Voglino P. M. Vita Francesco Maria Carrano Luca Ambrosio Roberto Cammarata Gabriella Teresa Capolupo Damiano Caputo Filippo Carannante Chiara Cascone Francesco Esperto Tommaso Farolfi Luca Frasca Ida Francesca Gallo Giulia Gibin Giancarlo Giurazza Luca Improta Vincenzo La Vaccara

Abstract COVID-19 negatively affected surgical activity, but the potential benefits resulting from adopted measures remain unclear. The aim of this study was to evaluate change in activity and benefit perspective Italian surgeons on behalf SPIGC. A nationwide online survey practice before, during, after pandemic conducted March–April 2022 (NCT:05323851). Effects hospital-related patients’ management personal professional development across specialties were explored. Data demographics,...

10.1007/s13304-023-01613-5 article EN cc-by Updates in Surgery 2023-08-14

Background/Objectives: Treating psoriasis patients requires the consideration of potential underlying complications like latent viral infections and chronic kidney disease, which may influence therapy selection. Case presentation: A patient with end-stage disease (ESKD) undergoing hemodialysis (HD) was successfully treated bimekizumab, an IgG1 humanized monoclonal antibody inhibiting interleukin (IL)-17A IL-17F. This case appears to be first documented instance effective anti-IL-17A/IL-17F...

10.3390/jcm13082250 article EN Journal of Clinical Medicine 2024-04-12

To the Editor: Behbahani et al1Behbahani S. Baltz J.O. Droms R. al.Sarcoid-like reaction in a patient recovering from coronavirus disease 19 pneumonia.JAAD Case Rep. 2020; 6: 915-917https://doi.org/10.1016/j.jdcr.2020.07.026Abstract Full Text PDF PubMed Scopus (18) Google Scholar recently reported your journal rare case of sarcoid granulomas induced by cross-reactivity to SARS-CoV-2 infection. Since then, different types vaccines against COVID-19 have been produced. Among these, BNT162b2...

10.1016/j.jdcr.2021.12.042 article EN cc-by JAAD Case Reports 2022-01-21

After coronavirus disease 2019 (COVID-19) caused a global pandemic, vaccines were rapidly developed to control the spread of virus. Although they effective in most cases at protecting people from becoming seriously ill and being hospitalized, showed side effects, too. Among other adverse vaccine reactions, cutaneous eruptions following SARS-CoV-2 have been described literature, but are not well-characterized yet. We morphology timing spectrum reactions COVID-19 available Italy, which...

10.3390/jcm11133811 article EN Journal of Clinical Medicine 2022-06-30

Introduction: The term "atypical melanocytic nevus" (AMN) is used as a synonym for dysplastic nevus (DN) in clinical practice. Although the criteria diagnosis of AMN/DN by Agency Research on Cancer helps to differentiate from common acquired nevi, they do not have high degrees specificity, are similar those melanoma. Objectives: In this retrospective study we evaluated correlation and diagnostic concordance dermoscopy, confocal microscopy, histological examination 50 AMN. Methods: A graded...

10.5826/dpc.1401a36 article EN cc-by-nc Dermatology Practical & Conceptual 2024-01-31
Coming Soon ...